{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:24:14Z","timestamp":1786987454560,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.conctc.2024.101310","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T06:50:38Z","timestamp":1715928638000},"page":"101310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Study protocol: A randomized, double-blind, placebo-controlled trial of isavuconazole prophylaxis for the prevention of covid-19-associated pulmonary aspergillosis"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6632-9587","authenticated-orcid":false,"given":"Jeffrey D.","family":"Jenks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1653-2824","authenticated-orcid":false,"given":"Martin","family":"Hoenigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8518-5750","authenticated-orcid":false,"suffix":"3rd","given":"George R.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.conctc.2024.101310_bib3","article-title":"Invasive aspergillosis as an under-recognized superinfection in COVID-19","volume":"7","author":"Thompson","year":"2020","journal-title":"Open Forum Infect. Dis."},{"issue":"11","key":"10.1016\/j.conctc.2024.101310_bib4","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00134-012-2673-2","article-title":"Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study","volume":"38","author":"Wauters","year":"2012","journal-title":"Intensive Care Med."},{"issue":"4","key":"10.1016\/j.conctc.2024.101310_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/rccm.201612-2540LE","article-title":"Influenza-associated aspergillosis in critically ill patients","volume":"196","author":"van de Veerdonk","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.conctc.2024.101310_bib6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir. Med."},{"issue":"7","key":"10.1016\/j.conctc.2024.101310_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz247","article-title":"Outcomes in invasive pulmonary aspergillosis infections complicated by respiratory viral infections in patients with hematologic malignancies: a case-control study","volume":"6","author":"Magira","year":"2019","journal-title":"Open Forum Infect. Dis."},{"issue":"8","key":"10.1016\/j.conctc.2024.101310_bib8","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","article-title":"COVID-19-associated fungal infections","volume":"7","author":"Hoenigl","year":"2022","journal-title":"Nat Microbiol"},{"issue":"12","key":"10.1016\/j.conctc.2024.101310_bib9","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S2213-2600(22)00259-4","article-title":"An observational study of lung epithelial and myeloid immunity in influenza- and COVID-19-associated pulmonary aspergillosis","volume":"10","author":"Feys","year":"2022","journal-title":"Lancet Resp Med"},{"issue":"674","key":"10.1016\/j.conctc.2024.101310_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq6682","article-title":"A B1a-natural IgG-neutrophil axis is impaired in viral- and steroid-associated aspergillosis","volume":"14","author":"Sarden","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.conctc.2024.101310_bib11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tim.2023.01.008","article-title":"How to lose resistance to Aspergillus infections","volume":"31","author":"Gangneux","year":"2023","journal-title":"Trends Microbiol."},{"issue":"9","key":"10.1016\/j.conctc.2024.101310_bib12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/myc.13292","article-title":"Incidence and mortality of COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis","volume":"64","author":"Mitaka","year":"2021","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.conctc.2024.101310_bib13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","article-title":"Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients- a multinational observational study by the European Confederation of Medical Mycology","volume":"28","author":"Prattes","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"issue":"2","key":"10.1016\/j.conctc.2024.101310_bib14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated COVID-19 patients in the ICU during the 1 first wave: the French multicenter MYCOVID study","volume":"10","author":"Gangneux","year":"2021","journal-title":"Lancet Resp Med"},{"issue":"11","key":"10.1016\/j.conctc.2024.101310_bib15","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3201\/eid2711.211174","article-title":"Multinational observational cohort study of COVID-19-associated pulmonary aspergillosis(1)","volume":"27","author":"Janssen","year":"2021","journal-title":"Emerg. Infect. Dis."},{"issue":"6","key":"10.1016\/j.conctc.2024.101310_bib16","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00134-021-06431-0","article-title":"Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial","volume":"47","author":"Vanderbeke","year":"2021","journal-title":"Intensive Care Med."},{"issue":"6","key":"10.1016\/j.conctc.2024.101310_bib17","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect. Dis."},{"issue":"11","key":"10.1016\/j.conctc.2024.101310_bib18","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1164\/rccm.202003-0543OC","article-title":"Clinical features of 85 fatal cases of COVID-19 from wuhan: a retrospective observational study","volume":"201","author":"Du","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.conctc.2024.101310_bib19","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","article-title":"Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients","volume":"71","author":"Chen","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.conctc.2024.101310_bib20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/myc.13096","article-title":"COVID-19 associated pulmonary aspergillosis","volume":"63","author":"Koehler","year":"2020","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.conctc.2024.101310_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","article-title":"COVID-19 associated pulmonary aspergillosis","volume":"202","author":"van Arkel","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.conctc.2024.101310_bib22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/myc.13135","article-title":"COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: an observational study from Pakistan","volume":"63","author":"Nasir","year":"2020","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.conctc.2024.101310_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.conctc.2024.101310_bib24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.conctc.2024.101310_bib26","article-title":"Large scale clinical trials: lessons from the COVID-19 pandemic","volume":"9","author":"Horsley","year":"2022","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.conctc.2024.101310_bib27","first-page":"1","article-title":"Combating COVID-19 vaccine inequity during the early stages of the COVID-19 pandemic","author":"Mortiboy","year":"2023","journal-title":"J Racial Ethn Health Disparities"},{"issue":"1","key":"10.1016\/j.conctc.2024.101310_bib28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13054-021-03753-9","article-title":"Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study","volume":"25","author":"Hatzl","year":"2021","journal-title":"Crit. Care"},{"issue":"3","key":"10.1016\/j.conctc.2024.101310_bib29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00134-021-06603-y","article-title":"Inhaled amphotericin B lipid complex for prophylaxis against COVID-19-associated invasive pulmonary aspergillosis","volume":"48","author":"Soriano","year":"2022","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.conctc.2024.101310_bib30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13054-021-03728-w","article-title":"Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis\/aspergillus tracheobronchitis","volume":"25","author":"Van Ackerbroeck","year":"2021","journal-title":"Crit. Care"},{"issue":"5","key":"10.1016\/j.conctc.2024.101310_bib31","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11046-023-00727-z","article-title":"Treatment of invasive aspergillosis: how it\u2019s going, where it\u2019s heading","volume":"188","author":"Boyer","year":"2023","journal-title":"Mycopathologia"},{"issue":"15","key":"10.1016\/j.conctc.2024.101310_bib32","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.conctc.2024.101310_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/cid\/ciad546","article-title":"High burden of COVID-19-associated pulmonary aspergillosis (CAPA) in severely immunocompromised patients requiring mechanical ventilation","volume":"78","author":"Feys","year":"2023","journal-title":"Clin. Infect. Dis."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865424000577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865424000577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T18:59:33Z","timestamp":1720810773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865424000577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":30,"alternative-id":["S2451865424000577"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2024.101310","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study protocol: A randomized, double-blind, placebo-controlled trial of isavuconazole prophylaxis for the prevention of covid-19-associated pulmonary aspergillosis","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2024.101310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101310"}}